Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglicose 0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Aster Medipharm Pvt Ltd

Salt Composition

Voglibose (0.2mg)

Overview Voglicose 0.2mg Tablet

Diabetics using Glucovance 0.2mg tablets manage post-prandial hyperglycemia. This medication assists in blood glucose regulation when diet and other comparable therapies prove insufficient. Administer this tablet immediately before meals; dosage and frequency are determined by your physician for optimal glycemic control. Discontinue use only under medical supervision; abrupt cessation risks dangerously elevated blood sugar, potentially leading to kidney complications or vision impairment. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as advised by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include abdominal discomfort (gas, pain, loss of appetite, constipation, diarrhea). Report persistent or troublesome side effects to your physician. While Glucovance 0.2mg does not independently cause hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; table sugar is ineffective. Inform your physician of any hepatic or renal dysfunction, or bowel inflammation (e.g., ulcerative colitis, Crohn's disease) before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Report all concurrent medications for safety assessment. Limit alcohol consumption due to increased hypoglycemia risk.

Primary Ingredients of Voglicose 0.2mg Tablet

The provided text is "undefined," therefore no rewriting is possible.

Uses of Voglicose 0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Voglicose 0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 0.2mg Voglicose tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Voglicose 0.2mg Tablet:

  • Skin rash
  • Flatulence
  • Abdominal pain
  • Diarrhea

How to use Voglicose 0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglicose 0.2mg Tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.

How Voglicose 0.2mg Tablet works:

Zyglow 0.2mg tablets are used to manage diabetes. They work by blocking enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus preventing post-meal spikes in blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglicose 0.2mg Tablet and alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Voglicose 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; yet, data from human trials remain scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Voglicose 0.2mg tablets safely. Studies in humans show minimal risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Voglicose 0.2mg tablets.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Voglicose 0.2mg tablets cautiously. Dosage modification of Voglicose 0.2mg tablets may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Voglicose 0.2mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

What if you forget to take Voglicose 0.2mg Tablet :

Omit any missed Voglicose 0.2mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Voglicose 0.2mg Tablet

LabelValue
Type of Compound A compound derived from valiolamine
Potential for Dependence None.
Type of Medication Medication for diabetes
Mechanism of Action Agents that block alpha-glucosidase

FAQs on Voglicose 0.2mg Tablet

Studies show Voglicose 0.2mg tablets, at standard dosages, do not induce substantial weight reduction. Nevertheless, considerably elevated doses may interfere with nutrient assimilation, potentially resulting in weight loss. This drug is not indicated for obesity management; its use for weight loss is contraindicated. Physician consultation is mandatory prior to commencing treatment.
A 0.2mg Voglicose tablet is typically administered orally, three times a day, just before meals. Concurrently, a controlled diet may be recommended. If the tablet proves ineffective on its own, additional antidiabetic medications may be prescribed alongside a suitable diet. Dosage adjustments may be made by your physician if blood glucose control remains inadequate. Self-medication is discouraged; consult your doctor before commencing treatment.
Voglicose 0.2mg Tablet
53
MRP 62
14% off